Cargando…

Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma

BACKGROUND: The expression and function of ribosomal s6 protein kinase 4 (RSK4) in renal cell carcinoma (RCC) are unknown. METHODS: Immunohistochemistry was used to detect the expression of RSK4 in RCC, and the relationship between RSK4 expression and clinicopathological features as well as prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, L, Li, P, Yin, Z, Fu, G, Liao, D J, Liu, Y, Zhu, J, Zhang, Y, Wang, L, Yan, Q, Guo, Y, Shao, C, Huang, G, Wang, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778307/ https://www.ncbi.nlm.nih.gov/pubmed/23942078 http://dx.doi.org/10.1038/bjc.2013.463

Ejemplares similares

Prognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinoma
por: Liu, X, et al.
Publicado: (2014)

Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy
por: Mao, Y-P, et al.
Publicado: (2014)

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
por: Shao, Y-Y, et al.
Publicado: (2012)

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
por: Yan, D-W, et al.
Publicado: (2010)

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
por: Toms, S. A., et al.
Publicado: (2018)

Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study
por: Zhang, D S, et al.
Publicado: (2015)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
por: Lee, D-W, et al.
Publicado: (2013)

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
por: Zhang, B, et al.
Publicado: (2013)

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
por: Yang, J J, et al.
Publicado: (2017)

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
por: Procopio, G, et al.
Publicado: (2012)

A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women
por: Shen, S, et al.
Publicado: (2015)

Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer
por: Fan, X-J, et al.
Publicado: (2012)

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
por: Li, J, et al.
Publicado: (2014)

Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
por: Nouso, K, et al.
Publicado: (2008)

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
por: Beuselinck, B, et al.
Publicado: (2012)

Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system
por: OuYang, P-Y, et al.
Publicado: (2013)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
por: Gilabert, M, et al.
Publicado: (2013)

Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas
por: Meng, Z, et al.
Publicado: (2012)

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006)

Genetic analysis of the ELOVL6 gene polymorphism associated with type 2 diabetes mellitus
por: Liu, Y., et al.
Publicado: (2013)

Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma
por: Hofbauer, S L, et al.
Publicado: (2014)

Prognostic Factors in Cutaneous Squamous Cell Carcinoma: Is Patient Delay in Hospital Visit a Predictor of Survival?
por: Endo, Y., et al.
Publicado: (2011)

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
por: Cella, D, et al.
Publicado: (2012)

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
por: Des Guetz, G, et al.
Publicado: (2006)

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
por: Hsu, C-H, et al.
Publicado: (2010)

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma
por: Toh, C-K, et al.
Publicado: (2005)

sTREM-1 as a Prognostic Marker of Postoperative Complications in Cardiac Surgery
por: Golovkin, A. S., et al.
Publicado: (2012)

The impact of plasma epstein–barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study
por: Tang, L-Q, et al.
Publicado: (2014)

(18)F-FDG PET/CT surveillance at 3–6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma
por: Kim, J W, et al.
Publicado: (2013)

Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome
por: Wang, F S, et al.
Publicado: (2005)

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
por: Lamb, G W A, et al.
Publicado: (2012)

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
por: Yang, T-S, et al.
Publicado: (2010)

A Comparative Study on Efficacy and Safety of Propofol versus Dexmedetomidine in Sleep Apnea Patients undergoing Drug-Induced Sleep Endoscopy: A CONSORT-Prospective, Randomized, Controlled Clinical Trial
por: Zhao, L. L., et al.
Publicado: (2018)

Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography
por: Reid, T D, et al.
Publicado: (2012)

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
por: Massard, C, et al.
Publicado: (2007)

Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
por: Thompson Coon, J S, et al.
Publicado: (2009)

The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway
por: Mai, H, et al.
Publicado: (2016)

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia
por: Lee, C-Y, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5td0kbikoankqllfbck9r3845g